Financial Gravity Asset Management, Inc. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 153 filers reported holding PDL BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
Financial Gravity Asset Management, Inc. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2023$000.00%
Q4 2022$0
-100.0%
0
-100.0%
0.00%
Q1 2020$99,000
+3200.0%
35
-73.5%
0.00%
-100.0%
Q4 2019$3,000132
-10.2%
0.00%
Q3 2019$01470.0%0.00%
Q2 2019$0
-100.0%
1470.0%0.00%
-100.0%
Q1 2019$1,0000.0%147
-31.0%
0.00%0.0%
Q3 2018$1,0000.0%213
-4.9%
0.00%0.0%
Q2 2018$1,0000.0%224
-2.2%
0.00%0.0%
Q1 2018$1,0002290.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders